Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium oxybate versus placebo in idiopathic restless legs syndrome
2007-002074-58Phase 3Active
- Sponsor
- Instituto de Investigaciones del Sueño
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium oxybate in restless legs syndrome (RLS) (2 arms), sponsored by Instituto de Investigaciones del Sueño. Primary endpoint: Change in IRLS total score. Started Nov 2007; status: active.
02
Drugs
sodium oxybate
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2007-002074-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002074-58.